Array BioPharma (ARRY) Financials

Array BioPharma Inc (ARRY) is a biopharmaceutical company that focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer and other diseases. The company's financials provide a snapshot of its performance and financial health.

The income statement shows the company's revenue and expenses over a specific period. It includes information on gross profit, operating expenses, and net income from stockholders. In the case of Array BioPharma Inc, their income statement indicates the financial outcome of their operations.

Earnings before interest and taxes (EBIT) is a measure of a company's profitability before deducting interest and tax expenses. Array BioPharma Inc's EBIT provides insight into its operational profitability.

EBITDA, or earnings before interest, taxes, depreciation, and amortization, is another profitability metric that gives a clearer picture of a company's operating performance. Array BioPharma Inc's EBITDA accounts for non-cash expenses and provides a measure of its operational cash flow.

The gross profit of Array BioPharma Inc represents the revenue remaining after subtracting the cost of goods sold. It gives an indication of the company's ability to generate profit from its core operations.

Net income from stockholders refers to the profit or loss attributable to the company's common shareholders. Array BioPharma Inc's net income measures the company's profitability after accounting for all expenses and taxes.

Total revenue represents the sum of all sales generated by Array BioPharma Inc during a specific period. It provides an overview of the company's overall performance and the demand for its products.

Turning to the balance sheet, it showcases the company's financial position at a specific point in time. Array BioPharma Inc's balance sheet displays its assets (including cash equivalents), liabilities, and stockholders' equity.

Cash equivalents refer to highly liquid assets that can be readily converted into cash. Array BioPharma Inc's cash equivalents are an important component of its overall liquidity position.

Net debt reflects the company's total debt minus its cash and cash equivalents. Array BioPharma Inc's net debt indicates the amount of debt the company must repay after considering its available cash resources.

Stockholders' equity represents the residual interest in the company's assets after deducting liabilities. Array BioPharma Inc's stockholders' equity is a measure of the shareholders' investment in the company.

Total assets represent the full value of all assets owned by Array BioPharma Inc, including cash, investments, property, and equipment. This figure provides insight into the company's overall size and the resources it possesses.

Total debt refers to the amount of money Array BioPharma Inc owes to lenders or creditors. It includes both short-term and long-term debt obligations.

Total liabilities encompass all of Array BioPharma Inc's financial obligations, including both current and long-term liabilities. It includes items such as accounts payable, accrued expenses, and long-term debt.

Cash flow represents the movement of money into and out of Array BioPharma Inc. It includes cash inflows from operations, investments, and financing activities.

Financing cash flow refers to the movement of money related to the company's financing activities. Array BioPharma Inc's financing cash flow includes sources of cash such as issuing stock or taking on debt, and uses of cash such as repayment of debt or dividend payments.

Free cash flow measures the amount of cash a company generates after deducting capital expenditures necessary to maintain or expand its asset base. Array BioPharma Inc's free cash flow provides insight into its ability to generate additional cash for growth or distribution to shareholders.

Investing cash flow accounts for the acquisition or disposal of long-term assets by Array BioPharma Inc. It includes cash flows related to the purchase or sale of property, plant, and equipment or investments in other companies or securities.

Operating cash flow represents the cash generated from the core operations of Array BioPharma Inc. It provides a measure of the company's ability to generate cash from its day-to-day activities.